BLMH.c chart looks promising ahead of expected FQ3 report A perfect storm of sorts is brewing for Bloom Health Partners (CSE: BLMH) stock. As the company prepares to release its fiscal Q3 financial report, there are multiple technical indicators showing that a strong recovery is incoming.
The 50MA has entered into an inflection, after SP dropped 35% since making a 131% early this summer. On top of this, today's daily volume is considerably higher than the average for the past two and a half months. All of these indicators show there is buying excitement ahead of the company’s highly anticipated quarterly results.
At the time of the company’s FQ2 report, yearly earnings to date totaled $16.9 million. These earnings eclipse the company’s current valuation of $9.22 million. Given this extreme imbalance in the company’s P/E ratio, I expect its next quarterly results to strongly catalyze some bullish price action.
BLMH.c is currently trading at $.195.
https://ceo.ca/@newsfile/bloom-health-partners-reports-profitable-fiscal-q2